Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Non-Current Assets (2019 - 2026)

Updated

Revolution Medicines (RVMD) posted Non-Current Assets of $294.93 million for Q2 2026, up 16.5% from $253.13 million a year earlier and up 3.2% from the prior quarter.

Analysis

Revolution Medicines (RVMD) Non-Current Assets (2019 - 2026) Analysis & Trends

At the end of FY2025, Revolution Medicines' Non-Current Assets came in at $279.47 million, up 21.2% from FY2024.

  • Annual Non-Current Assets has increased for six consecutive years, with a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
  • In prior years, Revolution Medicines' Non-Current Assets was $230.67 million in FY2024 (+26.4%), $182.42 million in FY2023 (+20.2%), $151.75 million in FY2022 (+2.4%) and $148.22 million in FY2021 (+30.8%).
  • The Q2 2026 figure stands as the highest quarterly Non-Current Assets in data going back to Q4 2019.
  • On a year-over-year basis, Non-Current Assets has increased in each of the last 19 quarters, with growth averaging 27.4% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2025, with growth of 49.3%; the weakest was Q3 2021, with a decline of 0.7%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $285.82 million (Q1 2026), $279.47 million (Q4 2025) and $274.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 141.29 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 101.45 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 87.87 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 35.42 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 159.77 Bn
10 Revolution Medicines 37.70 Bn 27.90 Bn - 294.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 294.93 Mn
Mar 31, 2026 285.82 Mn
Dec 31, 2025 279.47 Mn
Sep 30, 2025 274.43 Mn
Jun 30, 2025 253.13 Mn
Mar 31, 2025 230.77 Mn
Dec 31, 2024 230.67 Mn
Sep 30, 2024 183.86 Mn
Jun 30, 2024 183.71 Mn
Mar 31, 2024 179.16 Mn
Dec 31, 2023 182.42 Mn
Sep 30, 2023 159.77 Mn
Jun 30, 2023 151.62 Mn
Mar 31, 2023 150.50 Mn
Dec 31, 2022 151.75 Mn
Sep 30, 2022 150.80 Mn
Jun 30, 2022 149.76 Mn
Mar 31, 2022 148.43 Mn
Dec 31, 2021 148.22 Mn
Sep 30, 2021 111.44 Mn
API Access

Revolution Medicines Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=RVMD&period=max&api_key=YOUR_API_KEY